Musk can make shock go to to Beijing as Tesla’s China-built cars and trucks pass information safety procedures

Musk can make shock go to to Beijing as Tesla’s China-built cars and trucks pass information safety procedures


Critical Points
  • Regional Chinese authorities have taken out restrictions on Tesla cars and trucks following the company’s China-designed motor vehicles passed the country’s data safety demands, the automaker stated Sunday.
  • The breakthrough came as Tesla CEO Elon Musk arrived in Beijing for an sudden conference with Chinese Leading Li Qiang, amid the initially important automobile clearly show in the city in four many years.
  • Musk’s take a look at to China on Sunday also elevated anticipations that Tesla’s driver-aid computer software “Whole Self Driving” would shortly be obtainable in the nation.



Supply

Kevin Hassett pivots to possible ‘Trump cards’ amid credit card battle with banks
Finance

Kevin Hassett pivots to possible ‘Trump cards’ amid credit card battle with banks

Key Points Kevin Hassett told Fox Business that U.S. banks could voluntarily provide credit cards to underserved Americans. President Donald Trump called for banks to cap credit card interest rates at 10%, an idea that has been roundly rejected by industry executives and their lobbyists this week. At least one major credit card issuer and […]

Read More
Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more
Finance

Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more

Check out some of the companies making headlines in midday trading: Novo Nordisk — The maker of the Wegovy obesity treatment jumped more than 4% as sales of its oral weight loss treatment got off to a strong start. In the first week of its launch, about 1.3% of Wegovy prescriptions were for the oral […]

Read More
Stocks making the biggest moves premarket: PNC, ImmunityBio, Coupang & more
Finance

Stocks making the biggest moves premarket: PNC, ImmunityBio, Coupang & more

Check out the companies making headlines before the bell. ImmunityBio — The biotech company rallied 22%, adding to a 30% rally in the previous session that was sparked by strong guidance for its bladder cancer drug Anktiva. ImmunityBio expects full-year revenue for the drug to jump 700%. Coupang — Shares rose more than 3% after […]

Read More